Login to Your Account



Anadys Raises $38.3M In Series C To Advance Hepatitis C Products

By Brady Huggett


Friday, July 26, 2002
Anadys - it's research focus neatly split - raised $38.3 million in its Series C round in what could be its last financing before testing the investment waters with an initial public offering. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription